Karrysa's Krusade

03/30/2026

Quick update on Karrysa, she hasn't been feeling well last few days. She had a follow up from her recent surgery last week & her drains were taken out. Today her back was really swollen & they wound up taking out large amounts of fluid , also the last remaining stitches..She left office & went home..by the time she made it home her whole back, gauze, shirt & sweat shirt where soaked & when she went to look at it she realized her incision was completely ripped open down to bones..I got the call at work to come help her to get back to get her to her surgeon..they were concerned about another surgery with all of her difficulties with this last surgery & the anesthesia..they opted for local & stitched up the several layers..so fingers crossed no infection will come, she has a follow up on Wednesday & again Monday to keep an eye on it..
Please once again keep Karrysa in your healing thoughts & prayers.

💪

03/13/2026

Karrysa is out of surgery...Im patiently waiting for her up in her room...I can't wait to see her...its been a long day so far !

12/09/2025

The possibility of breast cancer returning after treatment remains a significant concern for many survivors, with recurrence rates reaching as high as 30 percent because of dormant tumor cells.

These inactive cells can quietly persist in places like the bone marrow for years, escaping conventional therapies designed to attack rapidly dividing cancer cells.

A major study from the University of Pennsylvania may have uncovered a way to finally remove this hidden danger.

In this research, scientists evaluated a new use of two existing medications: hydroxychloroquine, commonly used for malaria and autoimmune disorders, and everolimus, a drug used for certain advanced cancers and immune suppression.

The trial involved 51 breast cancer survivors who were confirmed to have dormant tumor cells. The results were striking. When patients received both drugs together, 87 percent of dormant cells were eliminated, and none of the participants experienced a recurrence within three years of follow-up.

Even when taken separately, each drug resulted in survival rates above 90 percent, suggesting strong therapeutic potential.

A key breakthrough in the study is the understanding that dormant tumor cells behave very differently from active cancer cells. Because these cells remain in a resting state, they are far more difficult to detect and are often untouched by standard treatments.

Yet this same biology also exposes them to weaknesses that drugs targeting cellular survival mechanisms can exploit.

This discovery has the potential to transform how survivorship care is approached. Instead of simply observing patients for signs of relapse, doctors may eventually be able to actively eliminate dormant cells and significantly lower the risk of recurrence.

The research team at UPenn is already preparing larger clinical trials, working to refine dosing strategies and exploring other drug combinations that might further improve outcomes.

If future studies confirm these results, this strategy could become a new cornerstone of post-treatment breast cancer care, providing survivors with longer-lasting protection and the possibility of greater peace of mind.

12/03/2025

https://www.facebook.com/share/1HSQQsrq9A/

University of Colorado cancer researchers explore ways to overcome resistance to a standard treatment for triple-negative breast cancer.

11/20/2025

👏 BIG, BREAKING NEWS!👏
The Pennsylvania Legislature has passed Senate Bill 88 for NO-COST diagnostic breast imaging - that includes mammograms, breast MRIs and ultrasounds for individuals insured under PA law.

Thank you to sponsors Senator Kim Ward and Senator Frank Farry, to Rep. Gina H. Curry for introducing the House companion bill, and to Speaker Rep. Joanna McClinton for moving SB 88 forward. Thank YOU for contacting your state lawmakers and sharing the lifesaving importance of this legislation! Now on to the Governor's desk for signature.


pbcc.me/sb88passed

11/12/2025

https://www.facebook.com/share/1ChEBKCxzn/

The experimental vaccine trains the immune system to recognize HER2 proteins on breast tumors.

11/11/2025

11/06/2025

And our day begins..
Surgery will be between 5 to 6 hours.
Karrysa's Krusade


💪

11/06/2025

Please send healing thoughts & prayers for Karrysa..since her last surgery in May , she has had nothing but issues with infections,pain, biopsies different treatment plans ect. Tomorrow she will be going for yet another surgery....so we are not sure how this one will go until they are in there...so she needs all the positivity she can get.
Karrysa's Krusade


💪

10/12/2025

To say my heart is full, is definitely an understatement. I cannot thank everyone enough that have been supporting Karrysa through out this battle, the overwhelming love & support for her has humbled me to tears many times...I love you all & wish I could tag everyone to let you all know THANK YOU from the bottom of my heart. I wish we could have captured everyone in the picture that ROCKED THE RIBBON 🎀 for my warrior Karrysa today. We are truly blessed, even through all this horrific disease has brought to her, there is still hope & so much love & support for her❤️❤️

10/01/2025

Wow a year, a year has past since her surgery...I thought back then by now she would be cancer free, not still dealing with chemo, liver doctors & more surgeries...but here she is still fighting her best fight!!


💪